阿尔多斯特对心脏结构和功能的影响
Ekhlas Mahmoud Al-Hashedi1,2, Fuad A Abdu3
1Department of Internal Medicine, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
Current cardiology reviews
|March 1, 2024
概括
阿尔多直接损害心脏组织,导致结构变化,如高和纤维化,独立于血压. 阿尔多激素对抗剂可以逆转这些有害的心脏影响,降低心血管风险.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子医学是分子医学.
背景情况:
- 阿尔多斯特在心血管疾病和死亡率方面发挥着关键作用.
- 它通过益菌性和益缩性效应直接影响心脏结构和功能.
- 这些影响包括心肌原沉积,炎症和氧化应激.
研究的目的:
- 为了研究阿尔多中介心脏重塑的机制.
- 探索阿尔多在各种心血管疾病中的作用.
- 评估阿尔多激素对抗剂在缓解心脏损伤方面的潜力.
主要方法:
- 对阿尔多斯特对心脏影响的实验和临床证据的审查.
- 对阿尔多素对高血压,心力衰竭和心房动等疾病的影响的分析.
- 检查独立于血压的机制.
主要成果:
- 阿尔多激素诱导心脏结构重塑和功能障碍.
- 关键的病理途径包括心肌缩,纤维化,炎症和氧化应激.
- 心脏损伤通过独立于血压升高的机制发生.
结论:
- 阿尔多中介的心血管损伤源于心脏结构和功能上的改变.
- 阿尔多激素对抗剂显示出降低或逆转有害心脏变化的潜力.
- 向阿尔多素通路提供了心血管保护的治疗策略.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
Antihypertensive Drugs: Action of β1 Blockers
447
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
447
Antihypertensive Drugs: Angiotensin II Receptor Blockers
730
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
730
Antihypertensive Drugs: Potassium-Sparing Diuretics
545
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
545


